Detail
LncRNA Name | AK001796 |
Synonyms | MIR4435-2HG, AGD2, AK001796, LINC00978, MIR4435-1HG, MIR4435-2HG |
Region | GRCh38_2:111036776-111523376 Sequence |
Ensembl | ENSG00000172965 |
RefSeq | NR_015395 |
Circulating | ✘ |
Drug-resisitant | ✘ |
Prognostic | ✔ |
MiRNA | ✔ |
Variant | ✘ |
TF | ✘ |
Methylation | ✘ |
Cancer Name | lung cancer |
ICD-0-3 | C34 |
Methods | microarray, qPCR, RNAi, Cell proliferation assay etc. |
Sample | lung cancer tissues, cell lines (BEAS-2B, A549 and H446) |
Expression Pattern | up-regulated |
Function Description | AK001796, the lncRNA with the most clearly altered expression, was overexpressed in lung cancer tissues and cell lines, but its expression was downregulated in resveratrol-treated lung cancer cells. By monitoring cell proliferation and growth in vitro and tumor growth in vivo, we observed a significant reduction in cell viability in lung cancer cells and a slow growth in the tumorigenesis following AK001796 knockdown. We also found that AK001796 knockdown caused a cell-cycle arrest, with significant increases in the percentage of cells in G0/G1 in lung cancer cells. By using cell cycle pathway-specific PCR arrays, we detected changes in a number of cell cycle-related genes related to lncRNA AK001796 knockdown. |
Pubmed ID | 25888808 |
Year | 2015 |
Title | A novel long noncoding RNA AK001796 acts as an oncogene and is involved in cell growth inhibition by resveratrol in lung cancer. |
External Links |
Links for AK001796 | GenBank HGNC lncrnadb Noncode |
Links for lung cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.